Sign In   |   Register

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

The 2019 Joint European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) Dyslipidaemia Guidelines were released on 31 August during the ESC Congress, Paris, France. These novel ESC/EAS Guidelines on lipids provide important new advice on patient management, which should enable more clinicians to efficiently and safely reduce CV risk through lipid modification. What were the key changes to those published in 2016? In the video below, the EAS contributors Professor Alberico L. Catapano, Professor Lale Tokgozoglu, and Professor Olov Wiklund describe key changes and what they will mean for practicing clinicians.

Read the guidelines >>
What's new? Read the commentary >>


Interactive webinar series on the 2019 Dyslipidaemia Guidelines

Take the opportunity to understand how the new guidelines apply to your practice, and put your questions to the experts in these free interactive webinars. Experts from EAS take a look at how to use the Guidelines in practice. Each webinar comprises a 15-min presentation, followed by Q&A with the speaker. You can expect to learn:

  • What were the key changes in the 2019 Guidelines? What has changed from the earlier version?
  • What lies behind the changes? What is the new evidence?
  • And what do they mean for management of patients’ cardiovascular risk in practice?

Read more and register for free >>

 What's new - video explaning the key messages

EAS - a European platform for atherosclerosis research

Our Society is pan-European and seeks to drive education and development of research, diagnosis and treatment of atherosclerotic disease.

  • we provide a framework for concert scientific and clinical discussion of new developments in basic research, diagnosis and therapy of atherosclerosis

  • we drive improvement in the treatment and prevention of atherosclerotic disease we need to have clear, expert-led, evidence-based guidance that can be simply and universally implemented by general practitioners and healthcare professionals.

In an article in the scientific online magazine Impact from July 2019, EAS President, Professor Lale Tokgözoglu discusses the Society's strategies for success

Read the article (pg.4-5) >>

Member sign in

Access the Society journals



Log in to access Atherosclerosis >>

Calendar more

04/12/2019 » 10/12/2019
Extended abstract submission deadline for EAS Congress 2020 Geneva

Advanced Course in Rare Lipid Disease - Stockholm

EAS Joint session at the annual meeting of the Czech Atherosclerosis Society

Advanced Course in Rare Lipid Disease - St Petersburg

EAS Academy
EAS Journal
Become an EAS Member
Membership Software Powered by YourMembership  ::  Legal
This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.